Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
Clinical trial NCT00242775 · COMPLETED
Trial details
- NCT number
- NCT00242775
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 2100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.